SABCS Meeting News

Events
Product Theatre

December 2022

Product Theatre
December 7, 2022 @ 10:00 am – 11:00 am CST

Advancing the Standards of Breast Cancer Care with Comprehensive Somatic Next-Generation Sequencing, Germline Testing and AI-Driven Data

Product Theatre
December 7, 2022 @ 12:00 pm – 1:00 pm CST

Exploring Treatment Options in HER2+ Early Breast Cancer

Product Theatre
December 7, 2022 @ 2:00 pm – 3:00 pm CST

A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation

Product Theatre
December 7, 2022 @ 4:00 pm – 5:00 pm CST

Learn More About an FDA-Approved Treatment for Metastatic Triple-Negative Breast Cancer

Product Theatre
December 8, 2022 @ 10:00 am – 11:00 am CST

MammaPrint & BluePrint: Gene Expression Profiling for Risk of Distant Metastasis in Early-Staged Breast Cancer Tumors and Molecular Subtyping Driving its Growth

Product Theatre
December 8, 2022 @ 12:00 pm – 1:00 pm CST

The Predictive Power of the Breast Cancer Index H/I Biomarker: Extended Endocrine Therapy and Beyond

Product Theatre
December 8, 2022 @ 2:00 pm – 3:00 pm CST

Clinical Trial Data update for a HER2+ MBC treatment option

Product Theatre
December 8, 2022 @ 4:00 pm – 5:00 pm CST

Laying the Groundwork: Current and Future Applications of Signatera™ in Breast Cancer

Product Theatre
December 9, 2022 @ 10:00 am – 11:00 am CST

Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings

Product Theatre
December 9, 2022 @ 12:00 pm – 1:00 pm CST

The Evolving Role of the Oncotype Dx Breast Recurrence Score® Test and the Future of the Breast Cancer Care Continuum

Featured Product Theatre
December 9, 2022 @ 2:00 pm – 3:00 pm CST

The Efficacy and Safety of ENHERTU